P
Paolo Dionigi Rossi
Researcher at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Publications - 34
Citations - 462
Paolo Dionigi Rossi is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 10, co-authored 34 publications receiving 318 citations.
Papers
More filters
Journal ArticleDOI
Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study.
Paola Nicolini,Michele M. Ciulla,Gabriella Malfatto,Carlo Abbate,Daniela Mari,Paolo Dionigi Rossi,Emanuela Pettenuzzo,Fabio Magrini,Dario Consonni,Federico Lombardi +9 more
TL;DR: This study is novel in providing evidence of autonomic dysfunction in MCI, associated with orthostatic BP dysregulation, and the ongoing follow-up of the study population will determine its prognostic relevance as a predictor of adverse health outcomes.
Journal ArticleDOI
Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly
Beatrice Arosio,Claudio D'Addario,Cristina Gussago,Martina Casati,Enzo Tedone,Evelyn Ferri,Paola Nicolini,Paolo Dionigi Rossi,Mauro Maccarrone,Daniela Mari +9 more
TL;DR: The role of biomarkers in AD is addressed with a focus on the notion that PBMCs may serve as a peripheral laboratory to find molecular signatures that could aid in differential diagnosis with other forms of dementia and in monitoring of disease progression.
Journal ArticleDOI
Efficacy of Nutritional Interventions as Stand-Alone or Synergistic Treatments with Exercise for the Management of Sarcopenia.
Sarah Damanti,Domenico Azzolino,Domenico Azzolino,Carlotta Roncaglione,Beatrice Arosio,Beatrice Arosio,Paolo Dionigi Rossi,Matteo Cesari,Matteo Cesari +8 more
TL;DR: The purpose of this review is to provide an overview on the role of proteins and other key nutrients, alone or in combination with physical exercise, on muscle parameters.
Journal ArticleDOI
Leukocyte telomere length in Alzheimer's disease patients with a different rate of progression
Enzo Tedone,Beatrice Arosio,Beatrice Arosio,Federico Colombo,Evelyn Ferri,Delphine Asselineau,François Piette,Cristina Gussago,Joël Belmin,Sylvie Pariel,Khadija Benlhassan,Martina Casati,Anne Bornand,Paolo Dionigi Rossi,Paolo Mazzola,Giorgio Annoni,Mohamed Doulazmi,Jean Mariani,Laura Porretti,Dorothy Bray,Daniela Mari,Daniela Mari +21 more
TL;DR: PBMC from ADF may be characterized by an impaired response induced by Aβ and by a reduced proliferative response responsible for the longer telomeres, which might be a contributing factor in predicting the rate of AD progression.